Cancer Genetics Inc  

(Public, NASDAQ:CGIX)   Watch this stock  
Find more results for Rita Harris�
9.75
+0.28 (2.96%)
Sep 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.35 - 9.83
52 week 4.83 - 12.75
Open 9.45
Vol / Avg. 14,419.00/58,043.00
Mkt cap 93.28M
P/E     -
Div/yield     -
EPS -1.99
Shares 9.85M
Beta     -
Inst. own 17%
Nov 9, 2015
Q3 2015 Cancer Genetics Inc Earnings Release (Estimated) Add to calendar
Aug 11, 2015
Q2 2015 Cancer Genetics Inc Earnings Call - Webcast
Aug 11, 2015
Q2 2015 Cancer Genetics Inc Earnings Release
Jul 8, 2015
Cancer Genetics Inc at Cantor Fitzgerald Inaugural Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -118.99% -163.18%
Operating margin -105.46% -188.34%
EBITD margin - -180.11%
Return on average assets -48.12% -32.55%
Return on average equity -69.18% -41.60%
Employees 139 -
CDP Score - -

Address

201 State Rt 17 Fl 2
RUTHERFORD, NJ 07070-2597
United States - Map
+1-201-5289200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cancer Genetics, Inc. is an oncology diagnostics company focused on developing, commercializing and providing DNA-based tests and services. The business is based on demand for DNA-based diagnostic services from three main sectors, including cancer centers and hospitals, biotechnology and biopharmaceutical companies, and the research community. Its clinical offerings include its portfolio of proprietary tests targeting hematological, urogenital and HPV-associated cancers, in conjunction with ancillary non-proprietary tests. Biopharma services include laboratory and testing services performed for biopharmaceutical companies engaged in clinical trials. Discovery services provide the tools and testing methods for companies and researchers seeking to identify new DNA-based biomarkers for disease.

Officers and directors

John G. Pappajohn Chairman of the Board
Age: 86
Bio & Compensation  - Reuters
Panna L. Sharma President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Edward J. Sitar CPA Chief Financial Officer, Treasurer, Secretary
Age: 47
Bio & Compensation  - Reuters
Rita Shaknovich Medical Director, Vice President - Hematopathology Services
Bio & Compensation  - Reuters
Jane Houldsworth Ph.D. Vice President - Research & Development
Age: 56
Bio & Compensation  - Reuters
Raju S. K. Chaganti Ph.D. Director
Age: 82
Bio & Compensation  - Reuters
Edmund M. Cannon Independent Director
Age: 70
Bio & Compensation  - Reuters
Geoffrey Eric Harris Independent Director
Age: 53
Bio & Compensation  - Reuters
Howard McLeod Independent Director
Age: 49
Bio & Compensation  - Reuters
Franklyn G. Prendergast M.D., Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters